You are here: Home > Key Acute Care Pediatric Medications
Key Acute Care Pediatric Medications
This reference includes a combination of FDA-labeled as well as off-labeled indications. Refer to DailyMed for the labeling status of the individual medications.
See also: Key Acute Care Adult Medications
A
Drug | Indications/Dosage |
---|---|
Adenosine | SVT 0.1 mg/kg IV/IO rapid push (max 6 mg), 2nd dose 0.2 mg/kg IV/IO rapid push (max 12 mg) |
Albumin | Shock, Trauma, Burns 0.5 to 1 g/kg (10 to 20 mL/kg of 5% solution) IV/IO rapid infusion |
Albuterol | Asthma, Anaphylaxis (bronchospasm), Hyperkalemia
|
Aminophylline | Treatment of Phosgene induced pulmonary edema (off label - anecdotal evidence) Aminophylline 5- 6 milligrams/kilogram IV loading dose over 20 minutes (lean ideal body weight) followed by
|
Amiodarone | SVT, VT (with pulses) 5 mg/kg IV/IO load over 20 to 60 min (max 300 mg), repeat to daily max 15 mg/kg (or 2.2 g) Pulseless Arrest (ie, VF/pulseless VT) 5 mg/kg IV/IO bolus (max 300 mg), repeat to daily max 15 mg/kg (or 2.2 g) |
Amyl Nitrite | Antidote for Cyanide Toxicity
Amyl nitrite perle should be broken onto a gauze pad and heal under the nose, placed under the lip of a facemask, or over the Ambu-valve intake. The patient should inhale for 30 seconds of each minute and a new perle should be utilized every three minutes if sodium nitrite infusions will be delayed. Amyl nitrite is not FDA-approved.
See Hydrogen Cyanide - Prehospital Management and Hydrogen Cyanide - Emergency Department/Hospital Management Treatment section for cyanide specific dosing recommendations
|
Atropine Sulfate | Bradycardia (symptomatic)
Toxins/Overdose (eg, organophosphate, carbamate)
0.02 to 0.05 mg/kg (<12 years) OR 0.05 mg/kg (>12 years) IV/IO initially, repeat q 20 to 30 min until atropine effect (dry mouth, tachycardia, mydriasis) is observed or symptoms reverse
See Nerve Agents - Prehospital Management and Nerve Agents - Emergency Department/Hospital Management Treatment section for nerve agent specific dosing recommendations
|
C
Drug | Indications/Dosage |
---|---|
Calcium Chloride 10% | Hypocalcemia, Hyperkalemia, Hypermagnesemia, Calcium Channel Blocker Overdose Dosing for non-life-threatening situations, refer to Harriet Lane Handbook, or DailyMed for dosing recommendations
Cardiac Arrest or Severe Hypotension 20 mg/kg (0.2 mL/kg) IV/IO slow push during arrest or if severe hypotension, repeat PRN |
D
Drug | Indications/Dosage |
---|---|
Dexamethasone | Croup 0.6 mg/kg PO/IM/IV (max 16 mg) |
Dextrose (Glucose) | Hypoglycemia 0.5 to 1 g/kg IV/IO (D25W 2 to 4 mL/kg; D10W 5 to 10 mL/kg) |
Diazepam | Prolonged Seizures/Status Epilepticus Neonate - 0.3-0.75 mg/kg/dose IV Q 15-30 min x 2-3 doses
See Nerve Agents - Prehospital Management and Nerve Agents - Emergency Department/Hospital Management Treatment section for nerve agent specific dosing recommendations
|
Diphenhydramine | Anaphylactic Shock 1 to 2 mg/kg IV/IO/IM q 4 to 6 hours (max 50 mg) |
Dobutamine | Congestive Heart Failure, Cardiogenic Shock 2 to 20 μg/kg per minute IV/IO infusion; titrate to desired effect |
Dopamine | Cardiogenic Shock, Distributive Shock 2 to 20 μg/kg per minute IV/IO infusion; titrate to desired effect |
E
Drug | Indications/Dosage |
---|---|
Epinephrine | Pulseless Arrest, Bradycardia (symptomatic)
Hypotensive Shock 0.1 to 1 μg/kg per minute IV/IO infusion (consider higher doses if needed) Anaphylaxis
Asthma 0.01 mg/kg (0.01 mL/kg) 1:1000 SQ q 15 minutes (max 0.5 mg; 0.5 mL) Croup
Racemic epinephrine solution (2.25%)
Toxins/Overdose (eg, beta-adrenergic blocker, calcium channel blocker)
|
F
Drug | Indications/Dosage |
---|---|
Furosemide | Pulmonary Edema, Fluid Overload 1 mg/kg IV/IM (usual max 20 mg if not chronically on loop diuretic) |
H
Drug | Indications/Dosage |
---|---|
Hydrocortisone | Adrenal insufficiency 2 mg/kg IV bolus (max 100 mg) |
Hydroxocobalamin | Antidote for Cyanide Toxicity A dose of 70 mg/kg (not to exceed 5 grams initially) administered over 30 minutes is recommended. This dose can be given IV push in situations of cyanide induced cardiac arrest.
See Hydrogen Cyanide - Prehospital Management and Hydrogen Cyanide - Emergency Department/Hospital Management Treatment section for cyanide specific dosing recommendations
|
I
Drug | Indications/Dosage |
---|---|
Inamrinone | Myocardial Dysfunction and Increased SVR/PVR Loading dose: 0.75 to 1 mg/kg IV/IO slow bolus over 5 minutes (may repeat twice to max 3 mg/kg), then 5 to 10 μg/kg per minute IV/IO infusion |
Ipratropium Bromide | Asthma 250 to 500 µg INH q 20 minutes PRN x 3 doses |
L
Drug | Indications/Dosage |
---|---|
Lidocaine | VF/Pulseless VT, Wide-Complex Tachycardia (with pulses)
|
Lorazepam | Prolonged Seizures/Status Epilepticus 0.05-0.1 mg/kg/dose IV over 2-5 minutes, may repeat 0.05 mg/kg X1 in 10 -15 min, max dose 2 mg/dose |
M
Drug | Indications/Dosage |
---|---|
Magnesium Sulfate | Asthma (refractory status asthmaticus), Torsades de Pointes, Hypomagnesemia 25 to 50 mg/kg IV/IO bolus (pulseless VT) OR over 10 to 20 minutes (VT with pulses) OR slow infusion over 15 to 30 minutes (status asthmaticus) (max 2 g) |
Methylprednisolone | Asthma (status asthmaticus), Anaphylactic Shock
|
Midazolam | Prolonged Seizures/Status Epilepticus 0.2 – 0.3 mg/kg IM, IN. Buccal (max 10 mg) Refractory Status Epilepticus
See Nerve Agents - Prehospital Management and Nerve Agents - Emergency Department/Hospital Management Treatment section for nerve agent specific dosing recommendations
|
Milrinone | Myocardial Dysfunction and Increased SVR/PVR Loading dose: 50 to 75 μg/kg IV/IO over 10 to 60 minutes followed by 0.5 to 0.75 μg/kg per minute IV/IO/infusion |
N
Drug | Indications/Dosage |
---|---|
Naloxone | Narcotic (opiate) Reversal
|
Nitroglycerin | Congestive Heart Failure, Cardiogenic Shock
|
Norepinephrine | Hypotensive (usually distributive) Shock (ie, low SVR and fluid refractory) 0.1 to 2 μg/kg per minute IV/IO infusion; titrate to desired effect |
O
Drug | Indications/Dosage |
---|---|
Oxygen | Hypoxia, Hypoxemia, Shock, Trauma, Cardiopulmonary Failure, Cardiac Arrest Administer 100% O2 via high-flow O2 delivery system (if spontaneous ventilations) or ET (if intubated); titrate to desired effect |
P
Drug | Indications/Dosage |
---|---|
Pralidoxime | Nerve Agent/Organophosphate Antidote 20 mg/kg - 50 mg/kg IM, autoinjector or IV (max dose 2 grams)
See Nerve Agents - Prehospital Management and Nerve Agents - Emergency Department/Hospital Management Treatment section for nerve agent specific dosing recommendations
|
Procainamide | SVT, Atrial Flutter, VT (with pulses) 15 mg/kg IV/IO load over 30 to 60 minutes (do not use routinely with amiodarone) |
S
Drug | Indications/Dosage |
---|---|
Sodium Bicarbonate | Cardiac Arrest, Metabolic Acidosis (severe), Hyperkalemia See Harriet Lane Handbook for dosing for specific indications Routine use of sodium bicarbonate in cardiac arrest is not recommended. When used in special situations, the typical initial dose is 1 mEq/kg, and then the dosage should be guide by the bicarbonate concentration or calculated base deficit from blood gas analysis or laboratory measurement (Neumar et al, 2010). See Phosgene - Emergency Department/Hospital Management Treatment section for off label dosing recommendations
|
Sodium Nitrite | As soon as IV access has been achieved in a symptomatic patient DC the perles and initiate IV sodium nitrite (ASAP).
See Hydrogen Cyanide - Prehospital Management and Hydrogen Cyanide - Emergency Department/Hospital Management Treatment section for cyanide specific dosing recommendations
|
Sodium Nitroprusside | Cardiogenic Shock (ie, associated with high SVR), Severe Hypertension 1 to 8 μg/kg per minute (wt < 40 kg) OR 0.1 to 5 μg/kg per minute (wt > 40 kg) IV/IO infusion |
Sodium Thiosulfate | Antidote for Cyanide Toxicity IV sodium thiosulfate
See Hydrogen Cyanide - Prehospital Management and Hydrogen Cyanide - Emergency Department/Hospital Management Treatment section for cyanide specific dosing recommendations
|